Immunohistochemical Staining on an Excision Biopsy Specimen as a Diagnostic Modality for Rare Idiopathic Hepatocellular Adenoma: A Case Report

Authors

  • Juferdy Kurniawan Division of Hepatobiliary Department of Internal Medicine Faculty of Internal Medicine Universitas Indonesia Ciptomangunkusumo General National Hospital
  • Andri Sanityoso Division of Hepatobiliary Department of Internal Medicine Faculty of Internal Medicine Universitas Indonesia Ciptomangunkusumo General National Hospital
  • Toar JM Lalisang Division of Digestive Surgery Department of Surgery Faculty of Internal Medicine Universitas Indonesia Ciptomangunkusumo General National Hospital
  • Ening Krisnuhoni Department of Pathology Anatomy Faculty of Internal Medicine Universitas Indonesia Ciptomangunkusumo General National Hospital
  • Sahat Matondang Department of Radiology Faculty of Internal Medicine Universitas Indonesia Ciptomangunkusumo General National Hospital
  • Abirianty P Araminta Division of Hepatobiliary Department of Internal Medicine Faculty of Internal Medicine Universitas Indonesia Ciptomangunkusumo General National Hospital
  • Lutfie Lutfie Division of Hepatobiliary Department of Internal Medicine Faculty of Internal Medicine Universitas Indonesia Ciptomangunkusumo General National Hospital

Keywords:

liver adenoma, benign liver tumor, diagnosis, immunohistochemical marker, resection

Abstract

Hepatocellular adenoma is an extremely rare benign tumor of the liver which predominantly in young women. Its rare incidence with estimated 3-4 cases per 1.000.000 annually makes it a diagnostic challenge. Here we present a 30-year-old female patient with hepatocellular adenoma without classic risk factors. A series of work up tools have been performed in order to diagnose the condition. None but excision biopsy from segmental resection had been showed to increase diagnostic confidence. This case illustrates the role of immunohistochemical staining from excision biopsy as the best diagnostic modality of hepatocellular adenoma as well as therapeutic modality to prevent malignant transformation.

References

Chang CY, Hernandez-Prera JC, Roayaie S, Schwartz M, Thung SN. Changing epidemiology of hepatocellular adenoma in the United States: review of the literature. Int J Hepatol 2013. Article ID 604860. doi:10.1155/2013/604860.

Rooks JB, Ory HW, Ishak KG, et al. Epidemiology of hepatocellular adenoma: the role of oral contraceptive use. JAMA.1979;242(7):644-8.

Soe KL, Soe M, Gluud C. Liver pathology associated with the use of anabolic-androgenic steroids. Liver 1992;12:73.

Curry MP, Afdhal NH. Hepatic adenoma. In: Chopra, Sanjiv, eds. Up to date. Retrieved May 12, 2015, from http://www.uptodate.com/home.

Bioulac-Sage P, Balabaud C, Zucman-Rossi J. Subtype classification of hepatocellular adenoma. Dig Surg. 2010;27(1):39-45.

Van Aalten SM, Thomeer MG, Terkivatan T, et al. Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology. 2011;261(1):172-81.

Geller S, Petrovic L. Benign tumors and tumor-like conditions. Biopsy Interpretation of the Liver. 3rd ed. Philadelphia: Williams and Wilkins, 2003. p. 281-304.

Kahn ME, French S, Wang HL. Hepatocellular adenoma: Morphological and molecular variants and distinction from well-differentiated hepatocellular carcinoma. Pathol Case Rev. 2009;14:13-20.

Palladino E, Sommacale D, Siboni R, et al. Focal nodular hyperplasia and hepatocellular adenomas: What is new in 2013? Int J Hepatobiliary Pancreat Dis. 2014;4:15-25.

Dhingra S. Update on the new classification of hepatic adenomas: Clinical, molecular, and pathologic characteristics. Arch Pathol Lab Med. 2014;138:1090-7.

Grazioli L, Federle MP, Brancatelli G, Ichikawa T, Olivetti L, Blachar A. Hepatic adenomas: imaging and pathologic findings. Radiographics. 2001;21:877-94.

Ichikawa T, Federie MP, Grazioli L, Nalesnik M. Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology. 2000;214(3):861-8.

Charny CK, Jarnagin WR, Schwartz LH, et al. Management of 155 patients with benign liver tumors. Br J Surg. 2001;88:808-13.

Van der Windt DJ, Kok NF, Hussain SM, et al. Case-oriented approach to the management of hepatocellular adenoma. Br J Surg. 2006;93:1495-502.

Margolskee E, Bao F, Gonzalez AK, et al. Hepatocellular adenoma classification: a comparative evaluation of immuno-histochemistry and targeted mutational analysis. Diag Pathol. 2016;11:27.

Aalten SM, Vledder MG, Terkivatan T, Man RA, Leertouwer T, Ijzermans JN. Safety and efficacy of radiofrequency ablation for hepatocellular carcinoma. J Vasc Intervent Radiol. 2011;22(6):787-93.

Downloads

Published

2019-05-10

How to Cite

Kurniawan, J., Sanityoso, A., Lalisang, T. J., Krisnuhoni, E., Matondang, S., Araminta, A. P., & Lutfie, L. (2019). Immunohistochemical Staining on an Excision Biopsy Specimen as a Diagnostic Modality for Rare Idiopathic Hepatocellular Adenoma: A Case Report. Acta Medica Indonesiana, 51(1), 63. Retrieved from https://actamedindones.org/index.php/ijim/article/view/212

Issue

Vol. 51 No. 1 (2019): Acta Medica Indonesiana

Section

CASE REPORT

License

Copyright

The authors who publish in this journal agree to the following requirements:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a  Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.